Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT06420895 |
Other study ID # |
EDS-2023-02 |
Secondary ID |
|
Status |
Active, not recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
January 1, 2011 |
Est. completion date |
December 31, 2033 |
Study information
Verified date |
May 2024 |
Source |
Lille Catholic University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
This project aims to create a data warehouse based on care data of patients with an aortic
insufficiency admitted to the Groupement des Hôpitaux de l'Institut Catholique de Lille
(GHICL) since 2011.
The aim is to enable the utilisation of this data for research purposes.
Description:
All eligible patients will be informed about the collection of their data during their care
at the Valvulopathies Center of Groupement des Hopitaux de l'Institut Catholique de Lille
(GHICL). Their consent will be needed for the inclusion.
Data will be collected exclusively by the person responsible for implementing the data
processing and his/her authorised staff. For all patients, data will be collected
retrospectively, based on medical records (electronic or paper), and information available on
the various care software linked to the patient's file. There will not be changes in the the
patient's care.
At the GHICL Valvulopathy Centre, in accordance with European recommendations, patients with
aortic insufficiency are monitored as follows, depending on the severity of the pathology:
- Minimal aortic insufficiency: follow-up every 3-5 years (approximately) including
clinical examination and transthoracic echocardiogram (TTE)
- Moderate/medium aortic insufficiency: follow-up every 1-2 years with clinical
examination, laboratory tests and TTE.
- Significant aortic insufficiency: follow-up every 6-12 months including a clinical
examination, a biological assessment and a c+/- TTE coupled with an exercise test.
- Cardiac Magnetic Resonance Imaging (MRI) indicated as a second-line procedure after TTE
in cases of moderate/medium aortic insufficiency with arguments or doubts about an
underestimation of the severity of the aortic insufficiency on TTE, aortic insufficiency
of undetermined quantification on TTE, or significant aortic insufficiency on TTE to
confirm the severity using a multiparametric approach.
- TEE (transesophageal echocardiogram) is indicated as 2nd line after TTE in cases of
significant aortic insufficiency as part of the preoperative work-up or
moderate/undetermined aortic insufficiency on TTE.
The choice between cardiac MRI or TEE, or both, as second-line treatment after TEE, is left
to the clinician in current practice, in accordance with the recommendations.